Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of Vixotrigine in Healthy Volunteers
Neuropathic pain affects ~ 6.9–10% of the general population and leads to loss of function, anxiety, depression, sleep disturbance, and impaired cognition. Here, we report the safety, tolerability, and pharmacokinetics of a voltage‐dependent and use‐dependent sodium channel blocker, vixotrigine, cur...
Autori principali: | , , , , |
---|---|
Natura: | Articolo |
Lingua: | English |
Pubblicazione: |
Wiley
2021-07-01
|
Serie: | Clinical and Translational Science |
Accesso online: | https://doi.org/10.1111/cts.12935 |